Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020
Top Cited Papers
- 23 October 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 44 (1), 50-57
- https://doi.org/10.2337/dc20-1444
Abstract
OBJECTIVE To describe the relationship between type 2 diabetes and all-cause mortality among adults with coronavirus disease 2019 (COVID-19) in the critical care setting. RESEARCH DESIGN AND METHODS This was a nationwide retrospective cohort study in people admitted to hospital in England with COVID-19 requiring admission to a high dependency unit (HDU) or intensive care unit (ICU) between 1 March 2020 and 27 July 2020. Cox proportional hazards models were used to estimate 30-day in-hospital all-cause mortality associated with type 2 diabetes, with adjustment for age, sex, ethnicity, obesity, and other major comorbidities (chronic respiratory disease, asthma, chronic heart disease, hypertension, immunosuppression, chronic neurological disease, chronic renal disease, and chronic liver disease). RESULTS A total of 19,256 COVID-19–related HDU and ICU admissions were included in the primary analysis, including 13,809 HDU (mean age 70 years) and 5,447 ICU (mean age 58 years) admissions. Of those admitted, 3,524 (18.3%) had type 2 diabetes and 5,077 (26.4%) died during the study period. Patients with type 2 diabetes were at increased risk of death (adjusted hazard ratio [aHR] 1.23 [95% CI 1.14, 1.32]), and this result was consistent in HDU and ICU subsets. The relative mortality risk associated with type 2 diabetes decreased with higher age (age 18–49 years aHR 1.50 [95% CI 1.05, 2.15], age 50–64 years 1.29 [1.10, 1.51], and age ≥65 years 1.18 [1.09, 1.29]; P value for age–type 2 diabetes interaction = 0.002). CONCLUSIONS Type 2 diabetes may be an independent prognostic factor for survival in people with severe COVID-19 requiring critical care treatment, and in this setting the risk increase associated with type 2 diabetes is greatest in younger people.Keywords
Other Versions
Funding Information
- Diabetes UK
This publication has 36 references indexed in Scilit:
- Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009–2017Open Forum Infectious Diseases, 2019
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort StudyDiabetes Care, 2018
- A Tutorial on Multilevel Survival Analysis: Methods, Models and ApplicationsInternational Statistical Review, 2017
- Is caviar a risk factor for being a millionaire?: Table 1BMJ, 2016
- Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 DiabetesDiabetes Care, 2015
- Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysisCMAJ : Canadian Medical Association Journal, 2012
- Multiple imputation for missing data in epidemiological and clinical research: potential and pitfallsBMJ, 2009
- Quantifying the Risk of Infectious Diseases for People With DiabetesDiabetes Care, 2003
- Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.American Journal of Public Health, 1999